Like most industries, pharmaceutical and healthcare companies are on a similar basis when it comes to keeping their IT up to date and, more importantly, adopting new technologies to drive their business and become innovation leaders. The pharmaceutical sector was seen as a supplier of pills to the healthcare industry but did not want to work with stakeholders to roll out the latest consumer technology. The industry used to focus more on marketing efforts with doctors and medical teams than end users. Current trends indicate a growing demand for more patient-centered care, and we are better informed about how preventative measures can help us make lifestyle changes for a healthier future.
Like most industries, pharmaceutical and healthcare companies are on a similar basis when it comes to keeping their IT up to date and, more importantly, adopting new technologies to drive their business and become innovation leaders. The pharmaceutical sector was seen as a supplier of pills to the healthcare industry but did not want to work with stakeholders to roll out the latest consumer technology. The industry used to focus more on marketing efforts with doctors and medical teams than end users. Current trends indicate a growing demand for more patient-centered care, and we are better informed about how preventative measures can help us make lifestyle changes for a healthier future.
Pages : 127 | Published Date : 2023-07-03 | Report Code : FMC53452
Global Anti-obesity Therapeutics Market, Analysis, Size, Share, Trends, COVID-19 Impact, and Forecast 2022 - 2028, By Type (Centrally Acting Anti-obesity Therapeutics, Peripherally Acting Anti-obesity Therapeutics), By Application (Hospital, Clinic, Household, Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)